Search people, articles, bills, and more
This bill requires drug companies to disclose where their ingredients come from and identify the original manufacturers on product labels to help the government track the safety and availability of the U.S. drug supply.AI-written
Forces drug companies to list original manufacturers on medicine labels and report detailed supply chain data to the FDA four times a year to prevent shortages and improve safety transparency.
Most Americans don't realize that a huge portion of our medicine—or the chemicals used to make it—comes from factories in countries like China and India. If one of those factories shuts down or has a safety problem, it can lead to massive drug shortages in U.S. pharmacies. Currently, the FDA doesn't always have a clear, real-time map of which drugs rely on which specific factories.
By forcing this transparency, the government can better protect the drug supply. If this becomes law, the FDA can identify 'single points of failure' where many different brands all rely on one factory. For the average person, it means more reliable access to medicine and more information about the quality and origin of the pills they put in their bodies.
No reactions yet. Be the first to weigh in.
This bill requires drug companies to disclose where their ingredients come from and identify the original manufacturers on product labels to help the government track the safety and availability of the U.S. drug supply.AI-written
Forces drug companies to list original manufacturers on medicine labels and report detailed supply chain data to the FDA four times a year to prevent shortages and improve safety transparency.
Most Americans don't realize that a huge portion of our medicine—or the chemicals used to make it—comes from factories in countries like China and India. If one of those factories shuts down or has a safety problem, it can lead to massive drug shortages in U.S. pharmacies. Currently, the FDA doesn't always have a clear, real-time map of which drugs rely on which specific factories.
By forcing this transparency, the government can better protect the drug supply. If this becomes law, the FDA can identify 'single points of failure' where many different brands all rely on one factory. For the average person, it means more reliable access to medicine and more information about the quality and origin of the pills they put in their bodies.
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
| TYPE | AMOUNT | WHO |
|---|---|---|
| administrative | Deemed 'Misbranded' | Drug manufacturers who fail to include required origin information on labels |